We are live on ! Find out more
FRTX

Fresh Tracks Therapeutics, Inc. Common Stock
FRTX

Delisted

FRTX was delisted on the 18th of December, 2023.

Back to rankings

14 hedge funds and large institutions have $1.94M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

33% more capital invested

Capital invested by funds: $1.46M → $1.94M (+$481K)

17% more funds holding

Funds holding: 12 → 14 (+2)

Holders
14
Holders Change
+2
Holders Change %
+16.67%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PCM
Palisade Capital Management
New Jersey
+$1.65M
2
Renaissance Technologies
Renaissance Technologies
New York
+$121K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$114K
4
Northern Trust
Northern Trust
Illinois
+$19.5K
5
Victory Capital Management
Victory Capital Management
Texas
+$4.3K

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$664K
2
WEC
Winslow Evans & Crocker
Massachusetts
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
1
Palisade Capital Management
New Jersey
$1.13M +$1.65M +21,131 New
Renaissance Technologies
2
Renaissance Technologies
New York
$433K +$121K +1,546 +24%
Vanguard Group
3
Vanguard Group
Pennsylvania
$144K +$114K +1,461 +119%
MFG
4
Magnus Financial Group
New York
$125K – – –
BlackRock
5
BlackRock
New York
$53K – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$18K – – –
Northern Trust
7
Northern Trust
Illinois
$13K +$19.5K +249 New
NFG
8
Next Financial Group
Texas
$10K +$2.66K +34 +23%
Bank of America
9
Bank of America
North Carolina
$2K – – –
SPIA
10
Steward Partners Investment Advisory
New York
$2K – – –
Morgan Stanley
11
Morgan Stanley
New York
$2K +$1.17K +15 +47%
Victory Capital Management
12
Victory Capital Management
Texas
$2K +$4.3K +55 New
BI
13
BVF Inc
California
– -$664K -9,840 Closed
WEC
14
Winslow Evans & Crocker
Massachusetts
– -$2K -3 Closed
CA
15
Clearstead Advisors
Ohio
– +$78 +1 New
Wells Fargo
16
Wells Fargo
California
– +$78 +1 New

FRTX Hedge Fund Activity: Q1 2020 in Review

14 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q1 2020, worth a combined $1.94M — up 33% from $1.46M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new FRTX positions and 3 closed out — a net gain of 2 holders — while 4 added to existing stakes and 0 trimmed.

The largest buyer was Palisade Capital Management, opening a new position worth an estimated $1.65M. The largest seller was BVF Inc, exiting entirely with an estimated $664K sold.

  • 14 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q1 2020, up from 12 in Q4 2019.
  • Funds reported $1.94M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q1 2020, up 33% quarter-over-quarter.
  • 5 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q1 2020 and 3 closed out, a net change of +2 holders.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q1 2020 was Palisade Capital Management, an estimated $1.65M added.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q1 2020 was BVF Inc, an estimated $664K sold.

Based on aggregated 13F filings for Q1 2020.